57
Participants
Start Date
October 31, 2006
Study Completion Date
March 31, 2008
caloric restriction - 10%
Subjects maintained on 10% caloric restriction (caloric intake = 90% of baseline)
caloric restriction - 25%
Subjects maintained on 25% caloric restriction (caloric intake = 75% of baseline)
caloric restriction - 50%
Subjects maintained on 50% caloric restriction (caloric intake = 50% of baseline)
caloric restriction - Control
Subjects maintained on their baseline caloric intake (caloric restriction = none)
Pfizer Investigational Site, Adelaide
Pfizer Investigational Site, North Adelaide
Lead Sponsor
University of Adelaide
OTHER
Royal Adelaide Hospital
OTHER
Pfizer
INDUSTRY